<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633343</url>
  </required_header>
  <id_info>
    <org_study_id>58526</org_study_id>
    <nct_id>NCT04633343</nct_id>
  </id_info>
  <brief_title>Effects of Different Tidal Volume Ventilation Strategies on Fontan Flow and Hemodynamics</brief_title>
  <official_title>Effects of Different Tidal Volume Ventilation Strategies on Fontan Flow and Hemodynamics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with Fontan circulation blood is not pumped to the lungs from a ventricle.&#xD;
      Instead the superior vena cava and inferior vena cava is connected to the pulmonary artery&#xD;
      and blood flow to the lungs occurs passively along this Fontan pathway. This passive blood&#xD;
      flow to the lungs occurs best when the patient is breathing on their own (spontaneous&#xD;
      ventilation). However for certain surgeries and procedures patients need to have an&#xD;
      endotracheal tube inserted and need to be muscle relaxed and receive positive pressure&#xD;
      ventilation. Prior studies have shown that positive pressure ventilation can reduce blood&#xD;
      flow to the lungs and consequently blood returning to the heart resulting in less blood&#xD;
      pumped out to the rest of the body (cardiac output). The purpose of this study is to&#xD;
      investigate if changing the volume of the positive pressure ventilation (tidal volume)&#xD;
      affects blood flow to the lungs and cardiac output in patients with Fontan circulation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If it can be shown that changing the tidal volume does affect the blood flow to the lungs and&#xD;
      cardiac output in patients with Fontan circulation the information can be used to learn from&#xD;
      this study to optimize the tidal volume ventilation, and therefore pulmonary blood flow and&#xD;
      cardiac output when Fontan patients come for general anesthesia. This is important because&#xD;
      the population of patients with Fontan circulation is increasing and an increasing number&#xD;
      will present for cardiac and non cardiac surgery when positive pressure ventilation will be&#xD;
      required. They may also spend time on the cardiac intensive care unit on a ventilator and&#xD;
      improving our knowledge on how best to ventilate them may help improve their overall hospital&#xD;
      outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transpulmonary gradient</measure>
    <time_frame>5 minutes of change in Tidal Volume (high vs low)</time_frame>
    <description>Effect of tidal volume changes (high vs low) on Transpulmonary gradient as measured as the difference between mean pulmonary artery pressure measured from right internal jugular (Fontan pressure line) and left atrial pressure measured by direct intracardiac pressure line. Both lines are placed for the scheduled clinical procedure and not solely for the purposes of the research study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood flow in inferior vena cava (IVC)</measure>
    <time_frame>5 minutes of change in Tidal Volume (high vs low)</time_frame>
    <description>Effect of tidal volume changes (high vs low) on blood flow in inferior vena cava (IVC) as measured by Transesophageal Echocardiography TEE)..</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic outflow tract stroke distance (velocity time integral)</measure>
    <time_frame>5 minutes of change in Tidal Volume (high vs low)</time_frame>
    <description>Effect of tidal volume changes (high vs low) on systemic outflow tract stroke distance (velocity time integral) as measured by Transesophageal Echocardiography. (TEE).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Fontan Physiology</condition>
  <arm_group>
    <arm_group_label>Small Volume Breath Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Small volume breath and fast breathing rate for 5 minutes when the patient is in the Operating room and on mechanical ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Large Volume Breath Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Large volume breath and slow breathing rate for 5 minutes when the patient is in the Operating room and on mechanical ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Small volume breath and fast breathing rate for 5 minutes</intervention_name>
    <description>Small volume breath and fast breathing rate delivered via mechanical ventilator.</description>
    <arm_group_label>Small Volume Breath Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Large volume breath and slow breathing rate for 5 minutes</intervention_name>
    <description>Large volume breath and slow breathing rate delivered via mechanical ventilator.</description>
    <arm_group_label>Large Volume Breath Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 2- 50 years of age&#xD;
&#xD;
          2. Patients with Fontan circulation undergoing cardio-thoracic surgery or undergoing&#xD;
             cardio-thoracic surgery for completion of Fontan circulation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Patients presenting for cardio-thoracic surgery without Fontan circulation or those not&#xD;
        coming for completion of Fontan circulation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manchula Navaratnam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manchula Navaratnam, MD</last_name>
      <phone>650-714-6014</phone>
      <email>manchuln@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Manchula Navaratnam</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

